✦ LIBER ✦

MP-08.09: Docetaxel, etoposide, and estramustine phosphate in the treatment of hormone-refractory prostate cancer

✍ Scribed by K. Nagao; T. Misumi; M. Sasaki; Y. Kawai; S. Eguchi; T. Hara; C. Ohmi; S. Sakano; H. Matsuyama; K. Naito

Book ID: 116948006
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 86 KB
Volume: 70
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2007.06.313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-08.16: Docetaxel and oral estramustin

MP-08.16: Docetaxel and oral estramustine phosphate in patients with hormone refractory prostate cancer

✍ T. Segawa; N. Masuda; Y. Shiraishi; H. Negoro; H. Oka; H. Iwamura; S. Moroi; K. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Safety and efficacy of docetaxel, estram

Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients

✍ Yoshihiro Nakagami; Makoto Ohori; Noboru Sakamoto; Shoji Koga; Riu Hamada; Tadas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Evaluation of docetaxel plus estramustin

Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer

✍ Akihiro Matsumoto; Atsushi Inoue; Satoshi Yokoi; Kazuyoshi Nozumi; Kanetaka Miya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Phase-II Study of Docetaxel, Estramustin

Phase-II Study of Docetaxel, Estramustine Phosphate, and Carboplatin in Patients with Hormone-Refractory Prostate Cancer

✍ Nobuyuki Kikuno; Shinji Urakami; Shigeru Nakamura; Takeo Hiraoka; Taijyu Hyuga; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Oral etoposide in the treatment of hormo

Oral etoposide in the treatment of hormone-refractory prostate cancer

✍ Maha H. Hussain; Kenneth J. Pienta; Bruce G. Redman; Glenn D. Cummings; Lawrence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

MP-19.10: Does intermittent low weekly d

MP-19.10: Does intermittent low weekly doses of docetaxel-estramustine have an impact on treatment outcome in hormone refractory prostate cancer?

✍ H. El-Shawaf; K.M. Galal; A.-M.M. Mourad 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB